Literature DB >> 21858393

Physicians' awareness of bisphosphonates-related osteonecrosis of the jaw.

Maha A Al-Mohaya1, Hesham I Al-Khashan, Adel M Mishriky, Lubna M Al-Otaibi.   

Abstract

OBJECTIVE: To assess the awareness and knowledge of physicians and dentists regarding bisphosphonates related osteonecrosis of the jaw (BRONJ).
METHODS: A cross-sectional descriptive study was carried out in the Department of Dentistry, Riyadh Military Hospital, Kingdom of Saudi Arabia from June to September 2010. Data were collected through a self-administered questionnaire distributed among a sample of physicians and dentists at the hospital.
RESULTS: A total of 222 valid completed responses were obtained (response rate: 82.2%). Less than one-third of the participants (31.5%) were aware of osteonecrosis of the jaw, while slightly more than half of them were treating patients with bisphosphonates (BP). None of the physicians had a correct response in all 4 knowledge questions. There were statistically significant associations between knowledge and qualification (p=0.019), years of experience (p=0.002), and specialty (p=0.034).
CONCLUSION: We found that physicians and dentists have low awareness and deficient knowledge regarding BRONJ, although most of them do prescribe BP to their patients. Therefore, intervention to raise awareness and knowledge among healthcare providers is needed.

Entities:  

Mesh:

Year:  2011        PMID: 21858393

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  6 in total

1.  Bisphosphonate-related osteonecrosis of the jaw: awareness and level of knowledge of Lebanese physicians.

Authors:  Lana El Osta; Badi El Osta; Sara Lakiss; Martine Hennequin; Nada El Osta
Journal:  Support Care Cancer       Date:  2015-02-13       Impact factor: 3.603

2.  Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals.

Authors:  Wanessa Miranda-Silva; Marco Aurélio Montezuma; Bernar Monteiro Benites; Julia Stephanie Bruno; Felipe Paiva Fonseca; Eduardo Rodrigues Fregnani
Journal:  Support Care Cancer       Date:  2020-03-06       Impact factor: 3.603

3.  Medication-related osteonecrosis of the jaw: knowledge and perceptions of medical professionals on the usage of bone modifying agents and dental referrals.

Authors:  Shruthi Acharya; Vathsala Patil; Vineetha Ravindranath; Adarsh Kudva; Krithi Nikhil
Journal:  J Med Life       Date:  2022-03

4.  Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) - A primary prevention strategy.

Authors:  Abdulrhman Al Abdullateef; Muhanad S Alhareky
Journal:  Saudi Pharm J       Date:  2020-05-15       Impact factor: 4.330

5.  The awareness and practice of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional survey.

Authors:  A Lum Han
Journal:  BMC Oral Health       Date:  2021-03-24       Impact factor: 2.757

6.  Awareness of the risk of developing medication-related osteonecrosis of the jaw among bisphosphonate users.

Authors:  Ahmad El-Ma'aita; Noor Da'as; Mais Al-Hattab; Yazan Hassona; Mohammad Al-Rabab'ah; Mohammad-Awni Al-Kayed
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.